Inventor · disambiguated record
Bernd Zetsche
Also filed as: ZETSCHE BERND
27 granted patents·26 pending applications·842 citations·filing 2015–2025
97Inventor score
Top patents by PatentIndex Score
53 records- 0198US12091709B2Crispr enzymes and systemsBROAD INST INC·Filed 2023·Granted Sep 17, 2024·7 cites·30 claims
- 0298US11091798B2CRISPR enzymes and systemsBROAD INST INC·Filed 2018·Granted Aug 17, 2021·32 cites·27 claims
- 0398US10876100B2Crispr enzyme mutations reducing off-target effectsBROAD INST INC·Filed 2017·Granted Dec 29, 2020·20 cites·29 claims
- 0498US10669540B2CRISPR enzymes and systemsBROAD INST INC·Filed 2017·Granted Jun 2, 2020·31 cites·41 claims
- 0598US10648020B2CRISPR enzymes and systemsBROAD INST INC·Filed 2017·Granted May 12, 2020·41 cites·15 claims
- 0698US10494621B2Crispr enzyme mutations reducing off-target effectsBROAD INST INC·Filed 2018·Granted Dec 3, 2019·35 cites·22 claims
- 0798US10377998B2CRISPR-CAS systems and methods for altering expression of gene products, structural information and inducible modular CAS enzymesBROAD INST INC·Filed 2016·Granted Aug 13, 2019·34 cites·15 claims
- 0898US9790490B2CRISPR enzymes and systemsBROAD INST INC·Filed 2015·Granted Oct 17, 2017·534 cites·60 claims
- 0997US11634755B2Crispr enzymes and systemsBROAD INST INC·Filed 2021·Granted Apr 25, 2023·8 cites·30 claims
- 1096US11781172B2Crispr enzymes and systemsBROAD INST INC·Filed 2019·Granted Oct 10, 2023·10 cites·35 claims
- 1196US11773432B2CRISPR enzymes and systemsBROAD INST INC·Filed 2021·Granted Oct 3, 2023·11 cites·30 claims
- 1296US11344609B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2021·Granted May 31, 2022·6 cites·34 claims
- 1396US11286478B2Cpf1 complexes with reduced indel activityBROAD INST INC·Filed 2017·Granted Mar 29, 2022·22 cites·28 claims
- 1496US11142760B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2021·Granted Oct 12, 2021·14 cites·30 claims
- 1595US11752202B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2022·Granted Sep 12, 2023·3 cites·28 claims
- 1695US11149259B2CRISPR-Cas systems and methods for altering expression of gene products, structural information and inducible modular Cas enzymesBROAD INST INC·Filed 2019·Granted Oct 19, 2021·11 cites·7 claims
- 1792US12344838B2CPF1 complexes with reduced indel activityBROAD INST INC·Filed 2022·Granted Jul 1, 2025·1 cites·32 claims
- 1892US12110490B2CRISPR enzymes and systemsBROAD INST INC·Filed 2016·Granted Oct 8, 2024·7 cites·33 claims
- 1992US11155803B2Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequenceBEAM THERAPEUTICS INC·Filed 2020·Granted Oct 26, 2021·13 cites·30 claims
- 2087US12264359B2CRISPR enzymes and systemsBROAD INST INC·Filed 2020·Granted Apr 1, 2025·1 cites·47 claims
- 2187US2025179453A1Crispr enzyme mutations reducing off-target effectsBROAD INST INC·Filed 2024·Application pending·0 cites
- 2281US12016908B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·0 cites·14 claims
- 2380US2025250617A1Crispr enzymes and systemsBROAD INST INC·Filed 2025·Application pending·0 cites
- 2480US2025250618A1Crispr enzymes and systemsBROAD INST INC·Filed 2025·Application pending·0 cites
- 2579US11866697B2Systems, methods, and compositions for targeted nucleic acid editingBROAD INST INC·Filed 2018·Granted Jan 9, 2024·1 cites·29 claims
- 2679US2025215425A1Novel crispr enzymes and systemsBROAD INST INC·Filed 2024·Application pending·0 cites
- 2777US12410468B2CRISPR enzymes and systemsBROAD INST INC·Filed 2020·Granted Sep 9, 2025·0 cites·25 claims
- 2877US12371737B2CRISPR enzymes and systemsBROAD INST INC·Filed 2020·Granted Jul 29, 2025·0 cites·40 claims
- 2976US12123032B2CRISPR enzyme mutations reducing off-target effectsBROAD INST INC·Filed 2019·Granted Oct 22, 2024·0 cites·13 claims
- 3076US2024132867A1Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequenceBEAM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3176US2024076651A1Systems, methods, and compositions for targeted nucleic acid editingBROAD INST INC·Filed 2023·Application pending·0 cites
- 3270US2022235347A1Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3370US2024035006A1Crystal structure of crispr cpf1BROAD INST INC·Filed 2022·Application pending·0 cites
- 3469US2024327813A1Crispr enzymes, methods, systems and uses thereofBEAM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3568US12435320B2CRISPR having or associated with destabilization domainsBROAD INST INC·Filed 2020·Granted Oct 7, 2025·0 cites·29 claims
- 3663US2024376468A1CIRCULAR GUIDE RNAs FOR CRISPR/CAS EDITING SYSTEMSBEAM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3760US2024167008A1Novel crispr enzymes, methods, systems and uses thereofBEAM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3857US12410416B2CRISPR enzymes and systems with modified pam specificityBROAD INST INC·Filed 2017·Granted Sep 9, 2025·0 cites·23 claims
- 3955US2022170027A1Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequenceBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4053US2023279373A1Novel crispr enzymes, methods, systems and uses thereofBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4153US2023101597A1Compositions and methods for treating alpha-1 antitrypsin deficiencyBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4252US2022098593A1Splice acceptor site disruption of a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic diseaseBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4351US2017306307A1Crispr having or associated with destabilization domainsBROAD INST INC·Filed 2017·Application pending·0 cites
- 4451US2022127594A1Compositions and methods for treating glycogen storage disease type 1aBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4550US2021317479A1Nucleic acid assemblies for use in targeted deliveryBROAD INST INC·Filed 2019·Application pending·0 cites
- 4649US2021079366A1Cas12a systems, methods, and compositions for targeted rna base editingBROAD INST INC·Filed 2018·Application pending·0 cites
- 4749US2021071163A1Cas12b systems, methods, and compositions for targeted rna base editingBROAD INST INC·Filed 2018·Application pending·0 cites
- 4847US2023140953A1Methods of editing a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic diseaseBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4946US2023193242A1Cas12b systems, methods, and compositions for targeted dna base editingBROAD INST INC·Filed 2018·Application pending·0 cites
- 5046US2020392473A1Novel crispr enzymes and systemsBROAD INST INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bernd Zetsche files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →